Advanced BioMedical Technologies, Inc. Revenue
Advanced BioMedical Technologies, Inc. reported Revenue of $180 for the 3-month period ending 2021-07-31, per its 10-Q filed 2021-09-13.
Discontinued › Income Statement
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax · last filed 2021-09-13
- Advanced BioMedical Technologies, Inc. revenue from contract with customer, excluding assessed tax for the quarter ending 2021-07-31 was $180.00, a 81.27% decline year-over-year.
- Advanced BioMedical Technologies, Inc. revenue from contract with customer, excluding assessed tax for the quarter ending 2021-04-30 was $95.00.
- Advanced BioMedical Technologies, Inc. revenue from contract with customer, excluding assessed tax for the quarter ending 2021-01-31 was $47.23K, a 21.93% decline year-over-year.
- Advanced BioMedical Technologies, Inc. revenue from contract with customer, excluding assessed tax for the quarter ending 2020-10-31 was $62.34K.
- Advanced BioMedical Technologies, Inc. revenue from contract with customer, excluding assessed tax for fiscal 2020 was $123.59K, a 960.20% increase from fiscal 2019.
- Advanced BioMedical Technologies, Inc. revenue from contract with customer, excluding assessed tax for fiscal 2019 was $11.66K.
| Period end | Revenue from Contract with Customer, Excluding Assessed Tax 3 month | Revenue from Contract with Customer, Excluding Assessed Tax 6 month | Revenue from Contract with Customer, Excluding Assessed Tax 9 month | Revenue from Contract with Customer, Excluding Assessed Tax 12 month |
|---|---|---|---|---|
| 2021-07-31 | $180.00 10-Q · filed 2021-09-13 | $275.00 derived: sum of 2 quarters · filed 2021-09-13 | $47.51K 10-Q · filed 2021-09-13 | $109.84K derived: sum of 4 quarters · filed 2021-09-13 |
| 2021-04-30 | $95.00 10-Q · filed 2021-06-21 | $47.33K 10-Q · filed 2021-06-21 | $109.66K derived: sum of 3 quarters · filed 2021-06-21 | $110.63K derived: sum of 4 quarters · filed 2021-09-13 |
| 2021-01-31 | $47.23K 10-Q · filed 2021-03-22 | $109.57K derived: sum of 2 quarters · filed 2021-03-22 | $110.53K derived: sum of 3 quarters · filed 2021-09-13 | $110.32K derived: sum of 4 quarters · filed 2021-09-13 |
| 2020-10-31 | $62.34K derived: 10-K 12 month − 10-Q 9 month · filed 2021-01-29 | $63.30K derived: sum of 2 quarters · filed 2021-09-13 | $63.09K derived: sum of 3 quarters · filed 2021-09-13 | $123.59K 10-K · filed 2021-01-29 |
| 2020-07-31 | $961.00 10-Q · filed 2021-09-13 | $750.00 derived: sum of 2 quarters · filed 2021-09-13 | $61.25K 10-Q · filed 2021-09-13 | |
| 2020-04-30 | -$211.00 10-Q · filed 2021-06-21 | $60.29K 10-Q · filed 2021-06-21 | ||
| 2020-01-31 | $60.50K 10-Q · filed 2021-03-22 | |||
| 2019-10-31 | $11.66K 10-K · filed 2021-01-29 |